Population-based case-control study of renin-angiotensin system genes polymorphisms and hypertension among Hispanics

Hypertension Research

Volumn 31, Issue 3, 2008, Pages 401-408

  Bautista, Leonelo E ^a   Vargas, Clara I ^b   Oróstegui, Myriam ^b   Gamarra, Germán ^b  

^a UNIVERSITY OF WISCONSIN SCHOOL OF MEDICINE AND PUBLIC HEALTH   (United States)

^b UNIVERSIDAD INDUSTRIAL DE SANTANDER   (Colombia)

Author keywords

Angiotensin converting enzyme; Colombia; Genetic polymorphism; Hypertension; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSINOGEN; DIPEPTIDYL CARBOXYPEPTIDASE;

ADULT; AGE DISTRIBUTION; ALLELE; ARTICLE; BODY MASS; CARDIOVASCULAR DISEASE; COLOMBIA; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; FAMILY HISTORY; FEMALE; GENDER; GENE DELETION; GENE INSERTION; GENE LINKAGE DISEQUILIBRIUM; GENETIC POLYMORPHISM; GENETIC RISK; GENOTYPE; HETEROZYGOSITY; HISPANIC; HOMOZYGOSITY; HUMAN; INCIDENCE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; PHYSICAL ACTIVITY; POPULATION BASED CASE CONTROL STUDY; RACE DIFFERENCE; RANDOM SAMPLE; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SYSTOLIC BLOOD PRESSURE;

ANGIOTENSINOGEN; BLOOD PRESSURE; CASE-CONTROL STUDIES; COLOMBIA; FEMALE; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; HYPERTENSION; MALE; MIDDLE AGED; MUTAGENESIS, INSERTIONAL; PEPTIDYL-DIPEPTIDASE A; POLYMORPHISM, GENETIC; RECEPTOR, ANGIOTENSIN, TYPE 1; RENIN-ANGIOTENSIN SYSTEM;

EID: 42649134852     PISSN: 09169636     EISSN: 13484214     Source Type: Journal    
DOI: 10.1291/hypres.31.401     Document Type: Article

References (38)

1. Marteau JB, Zaiou M, Siest G, Visvikis-Siest S: Genetic determinants of blood pressure regulation. J Hypertens 2005; 23: 2127-2143.
2. Pereira AC, Mota GF, Cunha RS, Herbenhoff FL, Mill JG, Krieger JE: Angiotensinogen 235T allele "dosage" is associated with blood pressure phenotypes. Hypertension 2003; 41: 25-30.
3. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al: Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71: 169-180.
4. Morise T, Takeuchi Y, Takeda R: Rapid detection and prevalence of the variants of the angiotensinogen gene in patients with essential hypertension. J Intern Med 1995; 237: 175-180.
5. Fardella CE, Claverie X, Vignolo P, Montero J, Villarroel L: T235 variant of the angiotensinogen gene and blood pressure in the Chilean population. J Hypertens 1998; 16: 829-833.
6. Rotimi C, Morrison L, Cooper R, et al: Angiotensinogen gene in human hypertension. Lack of an association of the 235T allele among African Americans. Hypertension 1994; 24: 591-594.
7. Rigat B, Hubert C, Alhenc-Gelas F, Cambien F, Corvol P, Soubrier F: An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J Clin Invest 1990; 86: 1343-1346.
8. Kainulainen K, Perola M, Terwilliger J, et al: Evidence for involvement of the type 1 angiotensin II receptor locus in essential hypertension. Hypertension 1999; 33: 844-849.
9. Hindorff LA, Heckbert SR, Tracy R, et al: Angiotensin II type 1 receptor polymorphisms in the cardiovascular health study: relation to blood pressure, ethnicity, and cardiovascular events. Am J Hypertens 2002; 15: 1050-1056.
10. Porto PI, Garcia SI, Dieuzeide G, Gonzalez C, Pirola CJ: Renin-angiotensin-aldosterone system loci and multilocus interactions in young-onset essential hypertension. Clin Exp Hypertens 2003; 25: 117-130.
11. Henderson SO, Haiman CA, Mack W: Multiple Polymorphisms in the renin- angiotensin-aldosterone system (ACE, CYP11B2, AGTR1) and their contribution to hypertension in African Americans and Latinos in the multiethinic cohort. Am J Med Sci 2004; 328: 266-273.
12. Bautista LE, Orostegui M, Vera LM, Prada GE, Orozco LC, Herran OF: Prevalence and impact of cardiovascular risk factors in Bucaramanga, Colombia: results from the Countrywide Integrated Noncommunicable Disease Intervention Programme (CINDI/CARMEN) baseline survey. Eur J Cardiovasc Prev Rehabil 2006; 13: 769-775.
13. Perloff D, Grim C, Flack J, et al: Human blood pressure determination by sphygmomanometry. Circulation 1993; 88: 2460-2470.
14. Fernandez-Llama P, Poch E, Oriola J, et al: Angiotensin converting enzyme gene I/D polymorphism in essential hypertension and nephroangiosclerosis. Kidney Int 1998; 53: 1743-1747.
15. Lindpaintner K, Pfeffer MA, Kreutz R, et al: A prospective evaluation of an angiotensin-converting-enzyme gene polymorphism and the risk of ischemic heart disease. N Engl J Med 1995; 332: 706-711.
16. Caulfield M, Lavender P, Farrall M, et al: Linkage of the angiotensinogen gene to essential hypertension. N Engl J Med 1994; 330: 1629-1633.
17. Hingorani AD, Brown MJ: A simple molecular assay for the C1166 variant of the angiotensin II type 1 receptor gene. Biochem Biophys Res Commun 1995; 213: 725-729.
18. Van Buuren S, Boshuizen HC, Knook DL: Multiple imputation of missing blood pressure covariates in survival analysis. Stat Med 1999; 18: 681-694.
19. Rubin D: Multiple Imputation for Non-Response in Surveys. New York, Wiley, 1987, p 76.
20. Greenland S: Modeling and variable selection in epidemiologic analysis. Am J Public Health 1989; 79: 340-349.
21. Cui J: Buckley-James method for analyzing censored data, with an application to a cardiovascular disease and an HIV/AIDS study. The Stata Journal 2005; 5: 517-526.
22. Staessen JA, Wang JG, Ginocchio G, et al: The deletion/insertion polymorphism of the angiotensin converting enzyme gene and cardiovascular-renal risk. J Hypertens 1997; 15: 1579-1592.
23. Hajar I, Kotchen TA: Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988-2000. JAMA 2003; 290: 199-206.
24. Bautista LE, Ardila ME, Gamarra G, Vargas CI, Arenas IA: Angiotensin-converting enzyme gene polymorphism and risk of myocardial infarction in Colombia. Med Sci Monit 2004; 10: CR473-CR479.
25. Kammerer CM, Gouin N, Samollow PB, et al: Two quantitative trait loci affect ACE activities in Mexican-Americans. Hypertension 2004; 43: 466-470.
26. Borecki IB, Province MA, Ludwig EH, et al: Associations of candidate loci angiotensinogen and angiotensin-converting enzyme with severe hypertension: the NHLBI Family Heart Study. Ann Epidemiol 1997; 7: 13-21.
27. Caulfield M, Lavender P, Newell-Price J, Kamdar S, Farrall M, Clark AJ: Angiotensinogen in human essential hypertension. Hypertension 1996; 28: 1123-1125.
28. Sethi AA, Nordestgaard BG, Gronholdt ML, Steffensen R, Jensen G, Tybjaerg-Hansen A: Angiotensinogen single nucleotide potymorphisms, elevated blood pressure, and risk of cardiovascular disease. Hypertension 2003; 41: 1202-1211.
29. Hegele RA, Brunt JH, Connelly PW: A polymorphism of the angiotensinogen gene associated with variation in blood pressure in a genetic isolate. Circulation 1994; 90: 2207-2212.
30. Tiret L, Ricard S, Poirier O, et al: Genetic variation at the angiotensinogen locus in relation to high blood pressure and myocardial infarction: the ECTIM Study. J Hypertens 1995; 13: 311-317.
31. Poirier O, Georges JL, Ricard S, et al: New polymorphisms of the angiotensin II type 1 receptor gene and their associations with myocardial infarction and blood pressure: the ECTIM study. Etude Cas-Temoin de l'Infarctus du Myocarde. J Hypertens 1998; 16: 1443-1447.
32. Wacholder S, Rothman N, Caporaso N: Population stratification in epidemiologic studies of common genetic variants and cancer: quantification of bias. J Natl Cancer Inst 2000; 92: 1151-1158.
33. Rosenberg NA, Pritchard JK, Weber JL, et al: Genetic structure of human populations. Science 2002; 298: 2381-2385.
34. Sesso HD, Buring JE; Rifai N, Blake GJ, Gaziano JM, Ridker PM: C-reactive protein and the risk of developing hypertension. JAMA 2003; 290: 2945-2951.
35. Arenas IA, Vargas CI, Davidge ST, Bautista LE: Angiotensin converting enzyme I/D gene polymorphism influences serum C-reactive protein level. Can J Cardiol 2006; 21: 112.
36. Magder LS, Hughes JP: Logistic regression when the outcome is measured with uncertainty. Am J Epidemiol 1997; 146: 195-203.
37. Winkelmann BR, Hager J: Genetic variation in coronary heart disease and myocardial infarction: methodological overview and clinical evidence. Pharmacogenomics 2000; 1: 73-94.
38. Katsuya T, Ishikawa K, Sugimoto K, Rakugi H, Ogihara T: Salt sensitivity of Japanese from the viewpoint of gene polymorphism. Hypertens Res 2003; 26: 521-525.